PBYI- Puma Biotechnology, Inc.
Across the last three months, Puma Biotechnology, Inc.'s insiders have reduced their positions by a net 44,058 shares worth roughly $364K.
PBYI sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
Insider Ownership
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 7.26M | $64.70M | - | |
| CFO | 240.0K | $2.14M | - | |
| Other | 205.3K | $1.83M | - | |
| Dir | 54.0K | $481.1K | - |
Activity
Buys and sells only
Transactions
10 filings · page 22
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 22, 2019 | Eyler Charles R | See Remarks | Sell | 713 | $24.80 | $17,682.40 | -2.2% | |
| Jan 3, 2019 | Auerbach Alan H62 | President And CEO | Sell | 4,424 | $20.67 | $91,444.08 | -0.1% | |
| Jan 3, 2019 | Eyler Charles R | See Remarks | Sell | 1,210 | $20.67 | $25,010.70 | -3.6% | |
| Jan 3, 2019 | Bryce Richard Paul | See Remarks | Sell | 1,210 | $20.67 | $25,010.70 | -3.7% | |
| Dec 3, 2018 | Eyler Charles R | See Remarks | Sell | 1,239 | $22.77 | $28,212.03 | -3.5% | |
| Jul 20, 2018 | Lo Steven | Chief Commercial Officer | Sell | 1,839 | $51.85 | $95,360.06 | -7.3% | |
| Jul 20, 2018 | Eyler Charles R | See Remarks | Sell | 610 | $51.95 | $31,689.50 | -1.7% | |
| Jul 20, 2018 | Bryce Richard Paul | See Remarks | Sell | 1,836 | $51.95 | $95,381.30 | -5.3% | |
| Jul 20, 2018 | Auerbach Alan H62 | President And CEO | Sell | 12,520 | $52.00 | $651,019.97 | -0.3% | |
| Jun 1, 2018 | Eyler Charles R | See Remarks | Sell | 1,211 | $53.00 | $64,183.00 | -3.3% |